Clear Cell Carcinoma of the Breast: A Rare Breast Cancer Subtype - Case Report and Literature Review

by Vilma Ratti, Olivia Pagani
Published 2015-11-01

Should age impact breast cancer management in young women? Fine tuning of treatment guidelines

by Matteo B. Suter, Olivia Pagani
Published 2018-06-01

Plasma HER2ECD a promising test for patient prognosis and prediction of response in HER2 positive breast cancer: results of a randomized study - SAKK 22/99

by Serenella Eppenberger-Castori, Dirk Klingbiel, Thomas Ruhstaller, Daniel Dietrich, Daniel Alexander Rufle, Karin Rothgiesser, Olivia Pagani, Beat Thürlimann
Published 2020-02-01

Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic

by Giuseppe Curigliano, Maria Joao Cardoso, Philip Poortmans, Oreste Gentilini, Gabriella Pravettoni, Ketti Mazzocco, Nehmat Houssami, Olivia Pagani, Elzbieta Senkus, Fatima Cardoso
Published 2020-08-01

Physicians communicating with women at genetic risk of breast and ovarian cancer: Are we in the middle of the ford between contradictory messages and unshared decision making?

by Marta Fadda, Pierre O Chappuis, Maria C Katapodi, Olivia Pagani, Christian Monnerat, Véronique Membrez, Sheila Unger, Maria Caiata Zufferey, Maria Caiata Zufferey
Published 2020-01-01

Estimation of historical control rate for a single arm de-escalation study – Application to the POSITIVE trial

by Zhuoxin Sun, Samuel M. Niman, Olivia Pagani, Ann H. Partridge, Hatem A. Azim, Jr., Fedro A. Peccatori, Monica Ruggeri, Angelo Di Leo, Marco Colleoni, Richard D. Gelber, Meredith M. Regan
Published 2020-10-01

Phase I trial of the androgen receptor modulator CR1447 in breast cancer patients

by Martin Zweifel, Beat Thürlimann, Salome Riniker, Patrik Weder, Roger von Moos, Olivia Pagani, Martin Bigler, Karin M Rothgiesser, Christiane Pilop, Hanne Hawle, Peter Brauchli, Coya Tapia, Wolfgang Schoenfeld, Cristiana Sessa
Published 2017-09-01

Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: characteristics and survival data

by Sabine Schmid, Dirk Klingbiel, Stefan Aebi, Aron Goldhirsch, Christoph Mamot, Elisabetta Munzone, Franco Nolè, Christian Oehlschlegel, Olivia Pagani, Bernhard Pestalozzi, Christoph Rochlitz, Beat Thürlimann, Roger von Moos, Patrik Weder, Khalil Zaman, Thomas Ruhstaller
Published 2019-09-01

Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy

by Ann H. Partridge, Samuel M. Niman, Monica Ruggeri, Fedro A. Peccatori, Hatem A. Azim, Jr., Marco Colleoni, Cristina Saura, Chikako Shimizu, Anna Barbro Sætersdal, Judith R. Kroep, Audrey Mailliez, Ellen Warner, Virginia F. Borges, Frédéric Amant, Andrea Gombos, Akemi Kataoka, Christine Rousset-Jablonski, Simona Borstnar, Junko Takei, Jeong Eon Lee, Janice M. Walshe, Manuel Ruíz Borrego, Halle CF. Moore, Christobel Saunders, Fatima Cardoso, Snezana Susnjar, Vesna Bjelic-Radisic, Karen L. Smith, Martine Piccart, Larissa A. Korde, Aron Goldhirsch, Richard D. Gelber, Olivia Pagani
Published 2021-10-01